To further examine the in vivo effects of CDK8 on tumor formation, MB cells transduced with either a control shRNA sequence (shNull) or shRNAs targeting CDK8 (shCDK8) were implanted intracranially into immunodeficient mice. This evidence concerns the gene CDK8 and neoplasm.